Kaiser Foundation Hospitals

Kaiser Foundation Hospitals was paid $90.75M by Medicaid between Jan 2018 and Dec 2024, across 301 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.

33Billing provider infoKAISER FOUNDATION HOSPITALS
ROSEVILLE, CA 95661

33aNPI1073811378assigned 03/10/2011

33bProvider typeGeneral Acute Care Hospital

28Total paid$90.75M

24GClaims1,661,850

24DCodes billed301

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#27 of 410

Median peer was paid$6.90M

This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	92,723	$6.37M
2019	186,122	$8.46M
2020	181,478	$12.45M
2021	239,728	$12.65M
2022	288,810	$15.40M
2023	332,672	$17.31M
2024incomplete	340,317	$18.11M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	25%	26,698	24,852	$22.80M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	13%	23,039	22,013	$11.82M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	8.2%	8,862	8,297	$7.41M
99282	Emergency department visit for the evaluation and management, low to moderate severity	8.1%	27,575	26,578	$7.36M
G0378	Hospital observation service, per hour	7.8%	7,661	5,809	$7.07M
99281	Emergency department visit for the evaluation and management, self-limited or minor	6.2%	42,491	40,273	$5.61M
74177	Computed tomography, abdomen and pelvis; with contrast material	4.0%	9,670	9,432	$3.65M
71046	Radiologic examination, chest; 2 views	1.6%	20,109	19,491	$1.49M
78815	Positron emission tomography (PET) for limited area imaging	1.6%	1,176	1,165	$1.49M
0450	Emergency room services	1.6%	29,029	26,153	$1.46M
70450	Computed tomography, head or brain; without contrast material	1.4%	9,630	9,339	$1.23M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.0%	4,077	4,011	$952K

289 more codes

71045	Radiologic examination, chest; single view	<1%	12,956	$796K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,190	$788K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,415	$755K
99199	Unlisted special service, procedure or report	<1%	14,115	$716K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,272	$695K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	13,005	$586K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,490	$452K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,553	$441K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	920	$436K
76830	Ultrasound, transvaginal	<1%	3,511	$432K
59025	Fetal non-stress test	<1%	2,588	$392K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	87,212	$356K
73630		<1%	4,163	$311K
0270		<1%	13,105	$305K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,142	$300K
70491		<1%	1,231	$295K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	19,912	$277K
73610		<1%	3,565	$275K
36415	Collection of venous blood by venipuncture	<1%	82,328	$257K
86900		<1%	4,389	$256K
74022		<1%	2,153	$253K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,845	$243K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	27,470	$243K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,458	$220K
72141		<1%	626	$216K
73560		<1%	3,176	$209K
96361	Intravenous infusion, hydration; each additional hour	<1%	12,457	$206K
73130		<1%	2,687	$203K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	12,600	$197K
73110		<1%	2,468	$192K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	52	$188K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	551	$187K
74018		<1%	2,345	$183K
93971		<1%	2,155	$182K
72100		<1%	1,672	$165K
73030		<1%	2,262	$165K
76770		<1%	1,266	$164K
80051		<1%	54,533	$163K
83880		<1%	11,753	$153K
96375	Therapeutic injection; each additional sequential IV push	<1%	15,378	$153K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,142	$153K
99499		<1%	1,823	$146K
82565		<1%	62,684	$132K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	4,365	$121K
73080		<1%	1,539	$119K
73140		<1%	1,489	$112K
84702		<1%	13,628	$110K
70486		<1%	593	$108K
81001		<1%	41,270	$108K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,303	$105K
86850		<1%	3,548	$105K
73590		<1%	1,373	$101K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	920	$97K
73090		<1%	1,273	$96K
82247		<1%	38,421	$95K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	7,029	$94K
84460		<1%	38,154	$94K
47562		<1%	13	$92K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	9,731	$88K
84450		<1%	34,953	$83K
86901		<1%	4,389	$82K
82947		<1%	55,483	$81K
84520		<1%	55,017	$79K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,663	$78K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,663	$77K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	4,645	$77K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	10,218	$77K
86923		<1%	377	$77K
83690		<1%	28,111	$74K
70496		<1%	254	$70K
84484		<1%	19,298	$69K
73502		<1%	989	$68K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	5,943	$64K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	4,481	$63K
87631		<1%	1,969	$62K
84075		<1%	31,069	$60K
J7030	Infusion, normal saline solution , 1000 cc	<1%	29,348	$60K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	696	$58K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,366	$56K
0637		<1%	114,363	$56K
83735		<1%	19,986	$56K
72040		<1%	744	$55K
D7140	Extraction, erupted tooth or exposed root	<1%	13	$54K
93976		<1%	515	$53K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,835	$51K
71250		<1%	432	$51K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	761	$48K
93970		<1%	374	$47K
85652		<1%	15,134	$46K
96376		<1%	4,512	$45K
76882		<1%	391	$45K
81003		<1%	26,424	$43K
70498		<1%	170	$41K
76870		<1%	341	$41K
80048	Basic metabolic panel (calcium, ionized)	<1%	11,993	$40K
87040		<1%	7,810	$40K
83605		<1%	8,141	$30K
73620		<1%	566	$29K
72146		<1%	89	$28K
80306		<1%	5,160	$28K
74019		<1%	245	$28K
41899	Unlisted procedure, dentoalveolar structures	<1%	139	$27K
J3490	Unclassified drugs	<1%	11,257	$27K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	17,468	$25K
85610		<1%	14,093	$25K
87088		<1%	8,796	$24K
82248		<1%	5,303	$23K
70544		<1%	73	$22K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	12,379	$22K
85027		<1%	3,932	$20K
0710		<1%	4,954	$19K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	11,975	$19K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	225	$18K
84100		<1%	9,897	$18K
85379		<1%	4,813	$18K
82077		<1%	4,658	$17K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	15	$16K
A9585	Injection, gadobutrol, 0.1 ml	<1%	636	$16K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,977	$15K
84132		<1%	4,714	$15K
73060		<1%	193	$15K
72070		<1%	155	$15K
87449		<1%	1,409	$15K
87324		<1%	1,370	$14K
82962		<1%	9,087	$14K
76801		<1%	88	$14K
Z7502		<1%	1,183	$13K
71101		<1%	121	$13K
82310		<1%	3,217	$13K
73564		<1%	120	$13K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	5,872	$13K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,418	$13K
85730		<1%	2,045	$12K
86140		<1%	5,724	$12K
82570		<1%	1,796	$11K
74183		<1%	26	$10K
73120		<1%	133	$10K
85378		<1%	2,495	$10K
73660		<1%	143	$10K
84443	Thyroid stimulating hormone (TSH)	<1%	1,872	$10K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	361	$9K
73552		<1%	129	$9K
83615		<1%	1,444	$9K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	710	$9K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	5,033	$9K
87506		<1%	158	$8K
80179		<1%	2,382	$8K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,678	$8K
72082		<1%	104	$8K
82040		<1%	2,188	$8K
82803		<1%	1,273	$8K
72131		<1%	52	$7K
73100		<1%	108	$7K
10060		<1%	413	$7K
0370		<1%	4,433	$7K
84156		<1%	1,690	$7K
72170		<1%	83	$7K
84295		<1%	1,632	$6K
73600		<1%	127	$6K
70543		<1%	12	$6K
88307		<1%	183	$6K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	72	$6K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,802	$6K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,788	$5K
J2060	Injection, lorazepam, 2 mg	<1%	2,810	$5K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	456	$5K
76857		<1%	41	$5K
J1815	Injection, insulin, per 5 units	<1%	4,275	$5K
C1769	Guide wire	<1%	249	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	446	$4K
84550		<1%	1,060	$4K
0250		<1%	17,438	$4K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,074	$4K
73221		<1%	12	$4K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,938	$4K
12011		<1%	587	$4K
82550		<1%	1,378	$3K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	17	$3K
97161		<1%	665	$3K
88342		<1%	38	$3K
12001		<1%	788	$3K
87081		<1%	987	$3K
76885		<1%	25	$3K
90715		<1%	165	$3K
70460		<1%	15	$3K
0272		<1%	544	$3K
82272		<1%	484	$3K
87070		<1%	880	$2K
86780		<1%	423	$2K
82140		<1%	402	$2K
87210		<1%	896	$2K
96367		<1%	585	$2K
29125		<1%	655	$2K
93017		<1%	26	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	673	$2K
73562		<1%	43	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	776	$2K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,234	$2K
80069		<1%	488	$2K
87205		<1%	554	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	1,965	$2K
82728		<1%	321	$2K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,300	$2K
0160		<1%	30	$2K
76536		<1%	12	$2K
76775		<1%	12	$1K
72081		<1%	25	$1K
86665		<1%	106	$1K
80349		<1%	1,568	$1K
99070		<1%	131	$1K
80061	Lipid panel	<1%	303	$1K
J8501	Aprepitant, oral, 5 mg	<1%	635	$977.98
29515		<1%	145	$977.52
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	320	$896.90
J1630	Injection, haloperidol, up to 5 mg	<1%	778	$861.35
89051		<1%	139	$784.23
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	406	$783.73
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	14	$762.50
88304		<1%	720	$693.43
90749		<1%	421	$619.43
70360		<1%	13	$602.06
96368		<1%	256	$580.77
J1940	Injection, furosemide, up to 20 mg	<1%	644	$565.75
76942		<1%	50	$523.76
86664		<1%	106	$516.68
D1206	Topical application of fluoride varnish	<1%	55	$498.00
94060		<1%	40	$489.56
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	13	$458.10
J1644	Injection, heparin sodium, per 1000 units	<1%	760	$435.61
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	145	$410.31
85008		<1%	403	$400.92
73020		<1%	13	$398.89
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	733	$383.56
90686		<1%	45	$372.32
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	229	$308.56
85007		<1%	156	$300.39
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	104	$293.95
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	227	$290.26
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	368	$268.79
0636		<1%	145	$263.05
0258		<1%	1,349	$254.46
J1171	Injection, hydromorphone, 0.1 mg	<1%	133	$205.24
12002		<1%	67	$204.00
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	130	$201.16
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	13	$193.68
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	<1%	27	$190.90
84155		<1%	110	$190.41
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	422	$183.07
87340		<1%	45	$179.50
J2785	Injection, regadenoson, 0.1 mg	<1%	13	$178.40
80325		<1%	360	$173.39
83935		<1%	27	$156.60
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,251	$149.55
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	73	$146.04
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	16	$138.75
84439		<1%	52	$125.31
89055		<1%	32	$104.83
C9113	Injection, pantoprazole sodium, per vial	<1%	771	$99.15
83550		<1%	62	$92.44
J3370	Injection, vancomycin hcl, 500 mg	<1%	37	$87.73
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	241	$78.00
J1836	Injection, metronidazole, 10 mg	<1%	93	$76.52
83540		<1%	62	$73.12
85045		<1%	29	$72.00
80320		<1%	285	$57.61
82607		<1%	25	$51.45
J2470	Injection, pantoprazole sodium, 40 mg	<1%	153	$48.41
97162		<1%	91	$47.97
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	19	$41.85
85014		<1%	131	$41.09
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	15	$40.66
J2550	Injection, promethazine hcl, up to 50 mg	<1%	33	$35.53
85018		<1%	97	$23.35
J1953	Injection, levetiracetam, 10 mg	<1%	29	$23.17
J7510	Prednisolone oral, per 5 mg	<1%	62	$21.26
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	41	$20.11
86706		<1%	14	$19.02
29505		<1%	12	$12.00
0990		0%	134	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	45	$0.00
80329		0%	76	$0.00
80324		0%	13	$0.00
G0008	Administration of influenza virus vaccine	0%	13	$0.00
80346		0%	316	$0.00
88302		0%	81	$0.00
76376		0%	392	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	498	$0.00
80356		0%	14	$0.00
P9016	Red blood cells, leukocytes reduced, each unit	0%	22	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOLLINS, JEFFREY (SR. VICE PRESIDENT,)

Same official

Other billing entities under COLLINS, JEFFREY

Full network →

Provider	Location	Paid
Ob-Gyn Associates of Anniston LLC	Anniston, AL	$697K
Jeffrey W Collins Od INC	Oxford, OH	$154K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.